healthytransplant.com | Advisory Committee Home | Advisory Committee

Advisory Committee

Howard J. Eisen, MD, FAHA, FACC, FACP

Howard J. Eisen, MD, FAHA, FACC, FACP

Howard Eisen obtained his MD from the University of Pennsylvania School of Medicine in 1981 where he was elected to Alpha Omega Alpha. Dr Eisen completed his internal medicine residency at the Hospital of the University of Pennsylvania (1981-4). This was followed by a fellowship in cardiovascular medicine at Washington University in St Louis and Barnes Hospital (1984-7), where he received training in the management of cardiac transplant recipients. He was subsequently on the faculty of the University of Pennsylvania School of Medicine and Temple University before joining the Drexel University College of Medicine and Hahnemann University Hospital as Chief of the Division of Cardiology in 2005.

Dr Eisen was an established investigator for the American Heart Association and is past president and continues to be a member of the Board of Governors of the American Heart Association Southeast Pennsylvania Affiliate. He is also a past chair of the Thoracic Committee of the American Society of Transplantation and is a member of the Editorial Board of the Journal of Heart and Lung Transplantation. Dr Eisen has also been named in Best Doctors in America, Castle-Connolly's Top Doctors in America, and Top Doctors in Philadelphia by Philadelphia Magazine.

John Gill, MD, MS, FRCPC

John Gill, MD, MS, FRCPC

John Gill obtained his MD from the University of British Columbia (UBC) in 1995. He completed his specialty training in internal medicine at the University of Western Ontario (1995-8) and his sub-specialty training in nephrology at UBC. Dr Gill then completed a clinical research fellowship at Tufts-New England Medical Center in Boston. During this time, he also completed a masters degree in clinical outcomes research at Tufts University. He joined the Division of Nephrology at St Paul’s Hospital, UBC, in July 2002.

Dr Gill is President of the Canadian Organ Replacement Register, Canada’s national registry of end organ failure patients. He is actively involved in clinical outcomes research in kidney transplant recipients and is an associate editor of the American Journal of Transplantation.

Andrew Keaveny

Andrew Keaveny

Andrew Keaveny is the Medical Director of Liver Transplantation at Mayo Clinic, in Jacksonville, Florida. He graduated from medical school at University College Dublin, Ireland, in 1990. He pursued postgraduate training in internal medicine and gastroenterology in Ireland and at Boston University Medical Center, Boston, MA. After completing a 1-year Transplant Hepatology Fellowship at the Lahey Clinic, Burlington, MA, he joined the staff at the Mayo Clinic School of Medicine as a Hepatologist in 2003.

Dr Keaveny holds diplomas from the American Board of Internal Medicine in internal medicine, gastroenterology, and transplant Hepatology. He is a Fellow of the Royal College of Physicians in Ireland and a member of the American College of Physicians, American Society of Transplantation, American Association of the Study of Liver Disease, and American Gastroenterological Association. He currently sits on the Liver and Intestines Advisory Council of the American Society of Transplantation. He is the Program Director of the Transplant Hepatology Fellowship at Mayo Clinic Florida.

Dr Keaveny has pursued research in a variety of areas in Hepatology and liver transplantation. His particular areas of interest include the evaluation of new treatments in portal hypertension, as well as the assessment and management of long-term complications after liver transplantation. He has been the principal or co-author of multiple book chapters, original articles, and case reports in peer-reviewed journals, including Liver Transplantation, the American Journal of Transplantation, and the American Journal of Gastroenterology.

Brendan M. McGuire, MD, MS

Brendan M. McGuire, MD, MS

Brendan McGuire graduated with a BSc in chemical engineering from the University of Notre Dame, Indiana, in 1984. He completed a MSc in bioengineering from Penn State University and a doctorate in medicine from the University of Pittsburgh in 1990. After completing his internal medicine residency and gastroenterology and hepatology fellowship at the University of Minnesota in 1996, Dr McGuire joined the faculty of the University of Alabama at Birmingham (UAB). He has volunteered his time on various committees for the United Network for Organ Sharing (UNOS) and for the American Society of Transplantation (AST).
Dianne B. McKay, MD

Dianne B. McKay, MD

Dianne B. McKay, MD completed her Nephrology and Transplantation fellowship at Brigham and Women's Hospital, Harvard Medical School and her transplantation research training at the Dana Farber Cancer Institute in Boston, Massachusetts. She joined the medical faculty of Brigham and Women’s Hospital in 1991 and served as the Associate Medical Director of Renal Transplantation until 2001 when she was recruited to The Scripps Research Institute in La Jolla, California.

Dr. McKay's clinical interests are focused on women’s health and transplantation and as such she founded the Women’s Health Community of Practice and has published widely on issues relevant to the life cycle of female transplant recipients. Her basic science work is focused on innate immunity and transplantation and she has identified critical mechanisms of allograft recognition that lead to the cascade of allograft rejection. Her research has been published widely in high profile journals, she has authored multiple book chapters, and she recently completed a book on transplantation for primary care physicians and community nephrologists titled Kidney Transplantation; a guide to the care of kidney transplant recipients.

Dr. McKay is an active member of the American Society of Transplantation, The American Society of Nephrology, The American Association of Immunologists, and the international Transplantation Society’s Women Leaders in Transplantation. She cares for transplant patients at the Sharp Kidney-Pancreas Transplant Program in San Diego, CA. Dr. McKay has been invited to speak nationally and internationally and she has received numerous honors and accolades for both her basic science and clinical research. She serves the American Society of Transplantation as the Chair of the Communications Committee, Chair of the Women’s Health Community of Practice, a member of the Ethics and Conflict Committee, member of the Awards and Grants Committee, and member of the Website Design Committee.

Alicia Neu

Alicia Neu

Alicia Neu received her MD from the University of Virginia School of Medicine in 1988. She completed her pediatric residency training and pediatric nephrology fellowship at the Johns Hopkins Hospital and then joined the pediatric nephrology faculty in 1994. Dr. Neu has served as Clinical Director in the Division of Pediatric Nephrology since 2000 and Medical Director of Pediatric Dialysis and Kidney Transplantation since 2001. She also serves as the director of the pediatric nephrology fellowship program.

Dr Neu's research and clinical interests include clinical outcomes in pediatric end-stage kidney disease, immunization in children with chronic kidney disease, and identifying barriers to the identification and treatment of hypertension in children. She has authored over 70 peer-reviewed articles, book chapters, and has invited reviews in these areas.

Dr Neu is a member of the American Board of Pediatrics Nephrology Subboard and the Executive Committee of American Academy of Pediatrics Section on Nephrology. She was recently selected as a pediatric nephrology representative to the Council of Pediatric Subspecialties. Dr Neu serves on the board of directors of the North American Pediatric Renal Trials and Collaborative Study, and is also vice-chair of the Participating Centers Committee and chair of the Special Studies Committee. She is Chair of the Executive Committee of the American Society of Transplantation’s Pediatric Community of Practice and was recently elected to the Council of the American Society of Pediatric Nephrology.

Philip Rosenthal, MD

Philip Rosenthal, MD

An internationally renowned children's liver disease specialist, Philip Rosenthal is the Director of Pediatric Hepatology, Medical Director of the Pediatric Liver Transplant Program, and a Professor of Pediatrics and Surgery at the University of California, San Francisco (UCSF). He is board-certified in pediatrics and pediatric gastroenterology and has a certificate of added qualification in transplant hepatology. Dr Rosenthal completed his medical training at the Downstate Medical Center and the Albert Einstein Medical Center in New York. He then completed a fellowship in pediatric gastroenterology at UCSF. He joined the UCSF faculty in 1995 after serving as Professor of Pediatrics at the University of California, Los Angeles (UCLA).

Dr Rosenthal is a prolific author, a recipient of a number of professional honors and awards, and is committed to clinical service, research, and education. Currently, he is pursuing research on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary atresia, use of bioartificial liver support utilizing porcine hepatocytes for patients with fulminant liver failure, as well as researching the quality of life following liver transplantation in children. Dr Rosenthal’s professional services to the public include television, newspaper, and radio interviews on various topics such as hepatitis A, B, and C, and liver transplants for local, national, and international audiences. He is consultant to organizations such as the American Liver Foundation, Parents of Kids with Infectious Diseases, the Alagille Syndrome Alliance, Studies of Pediatric Liver Transplantation (SPLIT), the Centers for Disease Control and Prevention (CDC), and the National Institute of Health (NIH).

Alexander Clark Wiseman, MD

Alexander Clark Wiseman, MD

Alexander Wiseman obtained his MD from the Washington University in St Louis in 1994. Dr Wiseman completed his internal medical residency at the University of California, San Francisco (1995-7); this was followed by a fellowship in nephrology at the University of Colorado Health Services Center (1997-2000). He was subsequently on the faculty at the University of Colorado in the Division of Renal Diseases and Hypertension, where he now serves as Associate Professor (since 2007). Dr Wiseman is also Director of the Renal Transplant Clinic, Medical Director of Islet Transplantation, and Medical Director of the Kidney and Pancreas Transplant Program at the University of Colorado Hospital.

Dr Wiseman has been the recipient of many honors and awards and is currently a member of the American Society of Nephrology and American Society of Transplantation. He has been invited to give over 30 extra-mural lectures and has served on the editorial boards of a number of respected journals, including the American Journal of Transplantation and the Journal of Clinical Endocrinology and Metabolism. Dr Wiseman has also authored over 15 peer-reviewed publications and multiple book chapters and reviews.